📌 Key Takeaways
- Topic: Ultra Pure Silica: What Purity Level You Need and Which Industries Use It
- Keywords: fumed silica alternative
- Published: 2026-11-20 08:32:05
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
What Is E551? Silicon Dioxide as a Food Additive, Uses and Safety
- Fumed Silica Brands Compared: Aerosil, Cab-O-Sil, HDK and Chinese Alternatives
- Yin, H. et al. Nanomedicine‐enabled photonic thermogaseous cancer therapy. Adv. Sci. 7, 1901954 (2020). Article CAS Google Scholar
- Silica Supplier Germany: Leading Producers and Sourcing Considerations
- Silica as an Insulating Filler: Dielectric Properties and Electronic Uses
- Imerys Silica: Product Range, Minerals and Applications
- Wang, H. et al. Degradable carbon-silica nanocomposite with immunoadjuvant property for dual-modality photothermal/photodynamic therapy. ACS Nano 14, 2847-2859 (2020). Article CAS PubMed Google Scholar
Is There a Quartz Sand Shortage? Causes, Impact and Supply Outlook
What is silica (SiO₂)?
how is silica made This review provides an overview of the development of MSNs in the biomedical field, highlighting some key research advances, briefly summarizing the types of MSNs developed by different research groups (M41S-series, SBA-series, FDU-series, KIT-series, etc.). Moreover, in view of the high versatility of MSNs-based nanocomposites for diagnostic and therapeutic applications, the current MSNs-based architectures and the types of nanocomposites by active elements are summarized. Subsequently, the purpose of surface functionalization of MSNs is examined. Further, we comprehensively review the biomedical applications of MSNs, among them biosensing, bioimaging, targeted disease therapy, and tissue engineering, etc. In particular, targeted therapeutic modalities based on various strategies are meticulously discussed. Finally, the current status of MSNs in clinical trials is presented. It is believed that this review will deliver a thorough understanding of MSNs involved in the development history, design, functionalization, and biomedical applications. In spite of numerous breakthroughs, the current challenges in MSNs research include three chief facets: systematic toxicity study, construction of straightforward but efficient MSNs-based nanoplatforms, and in-depth insight into the in vivo action mechanism.
What is the difference between fumed silica and precipitated silica?
cosmetic grade silica Tamarov, K. et al. Temperature responsive porous silicon nanoparticles for cancer therapy - spatiotemporal triggering through infrared and radiofrequency electromagnetic heating. J. Control. Release 241, 220-228 (2016). Article CAS PubMed Google Scholar
What drives silica raw material prices?
rheology modifier silica Dynamic therapy refers to an emerging therapeutic modality in which nanosensitizers are activated in the presence of exogenous stimuli such as light, ultrasound and electric field or endogenous tiny molecules such as H 2 O 2, and sequentially induce the in situ production of toxic free radicals for damaging crucial cellular components (e.g., lipids, proteins or DNA), thus leading to cell apoptosis or necrosis. 400, 401 Typical dynamic therapy strategies contain photosensitizer-mediated PDT, sonosensitizer-mediated SDT, nanocatalyst-mediated CDT and electrodynamic therapy (EDT). 401 In dynamic therapy processes, MSNs are outstanding substrate materials for loading nanosensitizers, and their roles include enhancing nanosensitizer stability, cutting down potential toxicity, supplying a suitable microenvironment for chemical reactions, and acting as a therapeutic nanoplatform to integrate multifunctional components. For example, PDT is an oxygen-dependent therapeutic modality, and its therapeutic efficiency is affected by the oxygen concentration. Nonetheless, the tumor microenvironment or biofilm microenvironment are always characterized with hypoxia. 402, 403, 404 For this reason, the simultaneous integration of some components with oxygen-producing functions, such as catalase, 405, 406 MnO 2, 407, 408 and Pt NPs, 409, 410 into the pores or surfaces of MSNs is expected to enhance the photodynamic performance. Comparable to PDT, SDT is also a non-invasive therapeutic modality and many of sonosensitizers are originated from photosensitizers, 411 such as Mn protoporphyrin-encapsulated biodegradable MSNs for MRI-guided tumor SDT, 412 and IR-780 sonosensitizer-loaded hollow MSNs for SDT of pancreatic cancer. 413 Differently, an extremely unique feature in MSNs-based SDT is that MSNs themselves are potentially effective sonosensitizers with the talent to enhance ultrasound-induced cavitation effect, without the introduction of additional sonosensitizers. 414 The principal reason for this is that MSNs possess big amounts of hydrophobic mesopores that can serve as bubble nucleation seeds in response to low-intensity ultrasound. 415, 416 CDT exploits the sickness microenvironment to activate the Fenton/Fenton-like reaction to produce strongly oxidizing •OH for particular and targeted disease therapy, which is first recommended by Zhang et al. in 2016, 417 and has subsequently attracted much attention from researchers. 418, 419 The efficiency of CDT is closely related to the H 2 O 2 content in the disease microenvironment, so researches have focused on introducing functional factors on MSNs matrix to enhance the content of H 2 O 2 reactants, thus increasing the yield of •OH. In this regard, Li et al. encapsulated both ultra-small CaO 2 and Fe 3 O 4 NPs in dendritic MSNs. In the acidic tumor microenvironment, CaO 2 reacts with H + to produce large amounts of H 2 O 2, leading to the enhancement of Fe 3 O 4 -mediated Fenton reaction. 420 In another study, natural glucose oxidase was used to consume intratumoral glucose while producing additional H 2 O 2 for the subsequent Fenton reaction catalyzed by Fe 3 O 4 NPs. 421 Besides, EDT is an emerging therapeutic approach newly proposed in 2019. 422 In this pioneering work, Pt NPs, assisted by a square-wave alternating current electric field, induced the breakdown of water molecules on their surface to generate cytotoxic •OH, which effectively inhibited tumor cell proliferation and triggered tumor cell apoptosis. 422 Regarding the MSNs-based EDT, Gu et al. designed a Pt/MSNs nanocomplex for the first time and encapsulated DOX into MSNs pore channels, followed by a layer of chitosan to stop the premature drug release. Under the tumor microenvironment and alternating current electric field, the designed MSNs-based nanoplatform effectively removed large-sized tumors (over 500 mm 3 ) while ensuring minimal side influences. This work is the first study to combine EDT and chemotherapy, and it provided new insights into the development of MSNs-based EDT nanoplatforms. 141
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.